AMED SCARDA「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」合同シンポジウム

講演情報

16:49 〜 16:50

[F1-19]FBXO11 constitutes a major negative regulator of MHC class II

*Yusuke Kasuga^1,3, Ryota Ouda¹, Masashi Watanabe², Xin Sun¹, Riko Izawa¹, Miki Kimura¹, Atsuki Takeishi^1,3, Tsutomu Tanaka^1,3, Shigetsugu Hatakeyama², Koichi Kobayashi^1,3 (1. Department of Immunology, Faculty of Medicine, Hokkaido University (Japan), 2. Department of Medical Chemistry, Faculty of Medicine, Hokkaido University (Japan), 3. Hokkaido University Institute for Vaccine Research and Development (Japan))

セッション詳細へ戻る